Azure Biosciences: Obtained new veterinary drug registration certificate.

Blue Bio announced that the "Fluconazole Ointment" jointly applied for by the company and its wholly-owned subsidiaries Blue to Pet Biotechnology and Animal Protection National Engineering Research Center Limited has been approved as a fourth category new veterinary drug, and has obtained a new veterinary drug registration certificate. This product is used to treat canine dermatophytosis, and was jointly developed by Blue to Pet Biotechnology, Nanjing Golden Shield Animal Pharmaceutical Industry, and other units, with a total research and development investment of 1.6443 million yuan. The acquisition of the new veterinary drug certificate is expected to bring new performance growth points to the company's business.